Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01512810 · ClinicalTrials.gov registry record · Phase 2
Intraoperative Pathological Evaluation for Surgical Treatment & Staging for Endometrial Cancer
A Phase 2 study, sponsored by Frederick R. Ueland, M.D..
- Completed
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
NCT01512810 is a Phase 2 study that has completed, run by Frederick R. Ueland, M.D.. The registered enrollment target is 200 participants.
The verdict
NCT01512810, a Phase 2 study, has completed, sponsored by Frederick R. Ueland, M.D..
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
Study Summary
Complete pelvic and para-aortic lymphadenectomy performed at the time of primary surgical staging for endometrial cancer increases operative time and surgical morbidity, but appears to be necessary in most high grade and deeply invasive cancers. To date, the Mayo Clinic approach has not been reproduced, and the investigators propose to validate their algorithm at the University of Kentucky utilizing intra-operative consultation (IOC). The preliminary data at the University of Kentucky for IOC and endometrial cancer outcomes suggest that the investigators are well-suited to perform this investigation. A surgical approach that is tailored to the patient's cancer biology is rational, supported by the recent literature, and medically compelling since the co-morbidities of many obese, low-risk EC patients put them at significantly increased perioperative risk for complete lymphadenectomy.
Interventions
- PROCEDURE Lymphadenectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2012-01 |
| Est. Completion | 2021-08-26 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01512810
The ClinicalTrials.gov registry entry for NCT01512810 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Frederick R. Ueland, M.D., which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lymphadenectomy is the first listed.
NCT01512810 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01512810 about?
NCT01512810 is a clinical study titled "Intraoperative Pathological Evaluation for Surgical Treatment & Staging for Endometrial Cancer". Complete pelvic and para-aortic lymphadenectomy performed at the time of primary surgical staging for endometrial cancer increases operative time and surgical morbidity, but appears to be necessary in most high grade and deeply invasive cancers. To date, the Mayo Clinic approach has not been reprodu...
What is the current status of trial NCT01512810?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2012-01. Estimated completion is 2021-08-26.
What interventions are being tested in trial NCT01512810?
The interventions under investigation include: Lymphadenectomy (PROCEDURE).
Who is sponsoring clinical trial NCT01512810?
This trial is sponsored by Frederick R. Ueland, M.D., which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.